CRON Q2 2021 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$981M

Q2 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$16M+16.4% YoY

Gross Profit

-$16M-101.0% margin

Operating Income

-$60M-385.5% margin

Net Income

-$179M-1146.3% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

-1.4%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$42M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$259M

Stockholders' Equity

$1.7B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$13M	+16.4%
Gross Profit	-$16M	-$4M	-297.9%
Operating Income	-$60M	-$101M	+40.6%
Net Income	-$179M	-$145M	-23.3%

Revenue Segments

Cannabis Flower

$12M74%

Cannabis Extracts

$4M24%

Product and Service, Other

$267,0002%

Geographic Segments

CANADA

$11M68%

ISRAEL

$2M15%

UNITED STATES

$2M14%

Other Countries

$421,0003%